Pruritus Assessment in Clinical Trials: Consensus Recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials

Authors

  • Sonja Ständer
  • Matthias Augustin
  • Adam Reich
  • Christine Blome
  • Toshiya Ebata
  • Ngoc Quan Phan
  • Jacek C. Szepietowski

DOI:

https://doi.org/10.2340/00015555-1620

Keywords:

itch, pruritus, visual analogue scale, patient benefit index, quality of life, data bank

Abstract

Chronic pruritus is a common symptom and there is an urgent need to test new anti-pruritic substances in high-quality clinical trials. However, no widely accepted standardized and validated method for objectively measuring pruritus is yet available. A special interest group of the International Forum for the Study of Itch has been established to assess scoring methods and questionnaires for use in clinical trials. This paper presents our current recommendations. The set of measures we recommend includes pruritus intensity scales, instruments for assessment of scratch lesions, chronic pruritus course, quality of life and patient benefits.

Downloads

Download data is not yet available.

Downloads

Published

2013-04-25

How to Cite

Ständer, S., Augustin, M., Reich, A., Blome, C., Ebata, T., Quan Phan, N., & Szepietowski, J. C. (2013). Pruritus Assessment in Clinical Trials: Consensus Recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. Acta Dermato-Venereologica, 93(5), 509–514. https://doi.org/10.2340/00015555-1620

Issue

Section

Articles